APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pramipexole Hydrochloride Extended Release Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pramipexole Hydrochloride Extended Release Tablets Industry Growth and Trends Forecast to 2032

28 December 202589 pages

Choose your research edition.

Industry ResearchPramipexole Hydrochloride Extended Release Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pramipexole Hydrochloride Extended Release Tablets Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Pramipexole Hydrochloride Extended Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pramipexole Hydrochloride Extended Release Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pramipexole Hydrochloride Extended Release Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global Pramipexole Hydrochloride Extended Release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pramipexole Hydrochloride Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pramipexole Hydrochloride Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pramipexole Hydrochloride Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pramipexole Hydrochloride Extended Release Tablets market include Tianjin Chasesun Pharmaceutical, Qilu Pharmaceutical (Hainan), Zhejiang Jingxin Pharmaceutical, Xiamen LP Pharmaceutical, Macleods Pharmaceuticals Ltd, Cspc Ouyi Pharmaceutical and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pramipexole Hydrochloride Extended Release Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pramipexole Hydrochloride Extended Release Tablets market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pramipexole Hydrochloride Extended Release Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pramipexole Hydrochloride Extended Release Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pramipexole Hydrochloride Extended Release Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pramipexole Hydrochloride Extended Release Tablets Market by Company

Tianjin Chasesun Pharmaceutical

Qilu Pharmaceutical (Hainan)

Zhejiang Jingxin Pharmaceutical

Xiamen LP Pharmaceutical

Macleods Pharmaceuticals Ltd

Cspc Ouyi Pharmaceutical

Boehringer Ingelheim International GmbH

Pramipexole Hydrochloride Extended Release Tablets Segment by Type

0.75mg

1.5mg

3.0mg

4.5mg

Others

Pramipexole Hydrochloride Extended Release Tablets Segment by Application

Hospital

Clinic

Others

Pramipexole Hydrochloride Extended Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pramipexole Hydrochloride Extended Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pramipexole Hydrochloride Extended Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pramipexole Hydrochloride Extended Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pramipexole Hydrochloride Extended Release Tablets companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pramipexole Hydrochloride Extended Release Tablets Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Region (2021-2026) Table 4. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Region (2027-2032) Table 6. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Type (2021-2026) Table 9. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Application (2021-2026) Table 24. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pramipexole Hydrochloride Extended Release Tablets Industry Trends Table 37. Pramipexole Hydrochloride Extended Release Tablets Industry Drivers Table 38. Pramipexole Hydrochloride Extended Release Tablets Industry Opportunities and Challenges Table 39. Pramipexole Hydrochloride Extended Release Tablets Industry Restraints Table 40. Global Pramipexole Hydrochloride Extended Release Tablets Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Company (2021-2026) Table 42. Global Pramipexole Hydrochloride Extended Release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pramipexole Hydrochloride Extended Release Tablets Key Company Headquarters & Area Served Table 44. Global Pramipexole Hydrochloride Extended Release Tablets Company, Product Type & Application Table 45. Global Pramipexole Hydrochloride Extended Release Tablets Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pramipexole Hydrochloride Extended Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Tianjin Chasesun Pharmaceutical Company Information Table 49. Tianjin Chasesun Pharmaceutical Business Overview Table 50. Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 52. Tianjin Chasesun Pharmaceutical Recent Development Table 53. Qilu Pharmaceutical (Hainan) Company Information Table 54. Qilu Pharmaceutical (Hainan) Business Overview Table 55. Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 57. Qilu Pharmaceutical (Hainan) Recent Development Table 58. Zhejiang Jingxin Pharmaceutical Company Information Table 59. Zhejiang Jingxin Pharmaceutical Business Overview Table 60. Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 62. Zhejiang Jingxin Pharmaceutical Recent Development Table 63. Xiamen LP Pharmaceutical Company Information Table 64. Xiamen LP Pharmaceutical Business Overview Table 65. Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 67. Xiamen LP Pharmaceutical Recent Development Table 68. Macleods Pharmaceuticals Ltd Company Information Table 69. Macleods Pharmaceuticals Ltd Business Overview Table 70. Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 72. Macleods Pharmaceuticals Ltd Recent Development Table 73. Cspc Ouyi Pharmaceutical Company Information Table 74. Cspc Ouyi Pharmaceutical Business Overview Table 75. Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 77. Cspc Ouyi Pharmaceutical Recent Development Table 78. Boehringer Ingelheim International GmbH Company Information Table 79. Boehringer Ingelheim International GmbH Business Overview Table 80. Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 82. Boehringer Ingelheim International GmbH Recent Development Table 83. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 85. North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2026) Table 86. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. North America Pramipexole Hydrochloride Extended Release Tablets Market Share Forecast by Country (2027-2032) Table 88. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 90. Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2026) Table 91. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Europe Pramipexole Hydrochloride Extended Release Tablets Market Share Forecast by Country (2027-2032) Table 93. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 95. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2026) Table 96. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Share Forecast by Country (2027-2032) Table 98. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 100. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2026) Table 101. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Share Forecast by Country (2027-2032) Table 103. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 105. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2026) Table 106. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share Forecast by Country (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pramipexole Hydrochloride Extended Release Tablets Product Image Figure 3. Global Pramipexole Hydrochloride Extended Release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 5. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Region: 2025 VS 2032 Figure 6. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Region (2021-2032) Figure 7. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 0.75mg Image Figure 13. Global 0.75mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. 1.5mg Image Figure 15. Global 1.5mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. 3.0mg Image Figure 17. Global 3.0mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. 4.5mg Image Figure 19. Global 4.5mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Type 2025 VS 2032 Figure 24. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Type (2021-2032) Figure 25. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Type (2021-2032) Figure 27. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Type (2021-2032) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinic Image Figure 32. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Application 2025 VS 2032 Figure 37. North America Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Application (2021-2032) Figure 38. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Application (2021-2032) Figure 40. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Pramipexole Hydrochloride Extended Release Tablets Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 47. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 50. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 53. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 56. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • 0.75mg
  • 1.5mg
  • 3.0mg
  • 4.5mg
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Tianjin Chasesun Pharmaceutical
  • Qilu Pharmaceutical (Hainan)
  • Zhejiang Jingxin Pharmaceutical
  • Xiamen LP Pharmaceutical
  • Macleods Pharmaceuticals Ltd
  • Cspc Ouyi Pharmaceutical
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2021-2032)
  5. 1.4.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2021-2026)
  6. 1.4.2 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032)
  8. 1.5.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (2021-2032)
2 Pramipexole Hydrochloride Extended Release Tablets Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 0.75mg
  3. 2.1.2 1.5mg
  4. 2.1.3 3.0mg
  5. 2.1.4 4.5mg
  6. 2.1.5 Others
  7. 2.2 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type
  8. 2.2.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Pramipexole Hydrochloride Extended Release Tablets Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Regions
  12. 2.3.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Type (2021-2026)
3 Pramipexole Hydrochloride Extended Release Tablets Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application
  6. 3.2.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Pramipexole Hydrochloride Extended Release Tablets Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Regions
  10. 3.3.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pramipexole Hydrochloride Extended Release Tablets Industry Trends
  2. 4.2 Pramipexole Hydrochloride Extended Release Tablets Industry Drivers
  3. 4.3 Pramipexole Hydrochloride Extended Release Tablets Industry Opportunities and Challenges
  4. 4.4 Pramipexole Hydrochloride Extended Release Tablets Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pramipexole Hydrochloride Extended Release Tablets Revenue (2021-2026)
  2. 5.2 Global Pramipexole Hydrochloride Extended Release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pramipexole Hydrochloride Extended Release Tablets Key Company Headquarters & Area Served
  4. 5.4 Global Pramipexole Hydrochloride Extended Release Tablets Company, Product Type & Application
  5. 5.5 Global Pramipexole Hydrochloride Extended Release Tablets Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pramipexole Hydrochloride Extended Release Tablets Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pramipexole Hydrochloride Extended Release Tablets Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pramipexole Hydrochloride Extended Release Tablets Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Tianjin Chasesun Pharmaceutical
  2. 6.1.1 Tianjin Chasesun Pharmaceutical Company Information
  3. 6.1.2 Tianjin Chasesun Pharmaceutical Business Overview
  4. 6.1.3 Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  6. 6.1.5 Tianjin Chasesun Pharmaceutical Recent Developments
  7. 6.2 Qilu Pharmaceutical (Hainan)
  8. 6.2.1 Qilu Pharmaceutical (Hainan) Company Information
  9. 6.2.2 Qilu Pharmaceutical (Hainan) Business Overview
  10. 6.2.3 Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical (Hainan) Recent Developments
  13. 6.3 Zhejiang Jingxin Pharmaceutical
  14. 6.3.1 Zhejiang Jingxin Pharmaceutical Company Information
  15. 6.3.2 Zhejiang Jingxin Pharmaceutical Business Overview
  16. 6.3.3 Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  18. 6.3.5 Zhejiang Jingxin Pharmaceutical Recent Developments
  19. 6.4 Xiamen LP Pharmaceutical
  20. 6.4.1 Xiamen LP Pharmaceutical Company Information
  21. 6.4.2 Xiamen LP Pharmaceutical Business Overview
  22. 6.4.3 Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  24. 6.4.5 Xiamen LP Pharmaceutical Recent Developments
  25. 6.5 Macleods Pharmaceuticals Ltd
  26. 6.5.1 Macleods Pharmaceuticals Ltd Company Information
  27. 6.5.2 Macleods Pharmaceuticals Ltd Business Overview
  28. 6.5.3 Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  30. 6.5.5 Macleods Pharmaceuticals Ltd Recent Developments
  31. 6.6 Cspc Ouyi Pharmaceutical
  32. 6.6.1 Cspc Ouyi Pharmaceutical Company Information
  33. 6.6.2 Cspc Ouyi Pharmaceutical Business Overview
  34. 6.6.3 Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  36. 6.6.5 Cspc Ouyi Pharmaceutical Recent Developments
  37. 6.7 Boehringer Ingelheim International GmbH
  38. 6.7.1 Boehringer Ingelheim International GmbH Company Information
  39. 6.7.2 Boehringer Ingelheim International GmbH Business Overview
  40. 6.7.3 Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  42. 6.7.5 Boehringer Ingelheim International GmbH Recent Developments
7 North America
  1. 7.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  3. 7.3 North America Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  3. 8.3 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  3. 10.3 South America Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst